Bortezomib
- Product NDC
- 50742-484
- 11-digit product format
- 507420484
- Labeler code
- 50742
- Product ID
- 50742-484_125ff955-0078-4a7e-a4d9-80739bcf302c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Bortezomib
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS; SUBCUTANEOUS
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA210824
- Marketing category
- ANDA
- Marketing start
- 2022-05-01
- Marketing end
- 0000-00-00
- Substance
- BORTEZOMIB
- Active strength
- 4 mg/1
- Pharmacologic classes
- Proteasome Inhibitor [EPC], Proteasome Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50742-484 | BORTEZOMIB INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [INGENUS PHARMACEUTICALS, LLC] | 3 | Legacy NDC | 20231229_c9bf8425-afa5-4171-b114-d83acb6d526d.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-484-01 | 50742048401 | 1 VIAL in 1 CARTON (50742-484-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL | 1 vial | 2022-05-01 | 0000-00-00 | No | No | Current |